In this study, we want to learn how mood and stress may affect the risk for heart disease in women during menopause.

Have you been diagnosed with oropharyngeal (tonsil or tongue base) cancer. If so, you may be able to take part in a research study testing markers to determine who may be appropriate for less aggressive therapy and markers to determine if recurrent tumors can be detected earlier.

Have you been diagnosed with CD30 negative peripheral T-cell lymphoma? If so, you may be able to take part in a research study that will look at the safety of adding the new study drug duvelisib, or the new study drug CC-486, to the standard chemotherapy treatment for your disease. Please contact us with questions about eligibility, or if you wish to know more.

Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.

Do you currently have a cancerous tumor that has advanced or progressed? Are you currently not on any standard of care treatment options? If so, you may be able to take part in a research study to see if a new drug may be able to slow the growth of your cancer. Travel reimbursement and compensation provided.

In this study, we will learn more about the safety and effectiveness of a study treatment that is injected into one of the kidneys of patients with Chronic Kidney Disease and Type 2 Diabetes.

The goal of this study is to learn more about what happens when cancer drugs that target specific changes in a tumor's DNA are used to treat tumors that have those DNA changes. We call the use of these types of drugs targeted therapy. A targeted therapy delivers a treatment that is aimed at a specific molecular feature of the cancer cell. The cancer cell being targeted contains a change in the DNA that results in the production of abnormal proteins. These proteins let the cancer cells grow uncontrollably or prevent the body from eliminating the cancer cells. The targeted therapy prevents the abnormal proteins from stimulating the growth of the cancer.

Have you been diagnosed with cervical cancer? If so, you may be able to take part in a research study that aims to identify a new non-invasive biomarker (blood test) to 1) detect cervical cancer during screenings and 2) track response to treatment, detect early recurrence and guide personalized treatment decisions. In this study we will measure levels of Circulating Tumor Human Papilloma Virus DNA (ctHPVDNA) levels in the blood and urine of women with newly diagnosed cervical cancer prior to receiving any treatment, and then compare this to the levels in samples collected after treatment (surgery of chemoradiation).

Have you been diagnosed with Pancreatic Cancer. If so, you may be able to take part in a research study looking at the safety of giving a drug called CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Do you have Barrett's Esophagus? Researchers are seeking volunteers to participate in a clinical trial that evaluates the effects obeticholic acid, a drug that reduces bile acids.